Inflammatory bowel disease: Role of diet, microbiota, life style

Translational Research

Volumn 160, Issue 1, 2012, Pages 29-44

  Neuman, Manuela G ^a   Nanau, Radu M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM SILICATE; ANTIBIOTIC AGENT; BCG VACCINE; CARBOHYDRATE; CORTICOSTEROID; DOXYCYCLINE; FISH OIL; GLUTAMINE; GLUTATHIONE; IBUPROFEN; IMMUNOMODULATING AGENT; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 6 FATTY ACID; ORAL CONTRACEPTIVE AGENT; OXYTETRACYCLINE; PARACETAMOL; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; PROSTAGLANDIN; SELENIUM; SUCROSE; SULFONAMIDE; TAP WATER; TETRACYCLINE; TITANIUM DIOXIDE; TRACE ELEMENT; TRANSFORMING GROWTH FACTOR BETA2;

BACTEROIDETES; BIFIDOBACTERIUM; BIOLOGICAL THERAPY; BREAST FEEDING; CLOSTRIDIUM DIFFICILE INFECTION; COMMENSAL; CROHN DISEASE; DAIRY PRODUCT; DIET THERAPY; DIETARY INTAKE; DISEASE COURSE; DISEASE TRANSMISSION; DRUG EXPOSURE; DRUG USE; ENTERITIS; ENVIRONMENTAL FACTOR; FAT INTAKE; FIRMICUTES; FOOD INTAKE; FRUIT; GENETIC PREDISPOSITION; HEALTH INSURANCE; HELICOBACTER PYLORI; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNIZATION; INCIDENCE; INFECTION; INFECTION RISK; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; LACTOBACILLUS; LACTOSE INTOLERANCE; LIFESTYLE MODIFICATION; LIPID METABOLISM; MEMBRANE MICROPARTICLE; MILK ALLERGY; MIXED INFECTION; MYCOBACTERIUM PARATUBERCULOSIS; NUTRIGENOMICS; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; OSTEOMALACIA; OSTEOPOROSIS; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PEDIATRICS; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; RAW MEAT; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STRESS; ULCERATIVE COLITIS; VEGETABLE; VITAMIN DEFICIENCY;

EID: 84862024612     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.09.001     Document Type: Review

References (53)

1. M.G. Neuman Immune dysfunction in inflammatory bowel disease Transl Res 149 2007 173 186
2. M.G. Neuman Signaling for inflammation and repair in inflammatory bowel disease Rom J Gastroenterol 13 2004 309 316
3. L.R. Ferguson, I. Peterman, C. Hübner, M. Philpott, and A.N. Shellin Uncoupling gene-diet interactions in inflammatory bowel disease (IBD) Genes Nutr 2 2007 71 73
4. C. Reiff, and D. Kelly Inflammatory bowel disease, gut bacteria and probiotic therapy Int J Med Microbiol 300 2010 25 33
5. F. Carbonnel, P. Jantchou, E. Monnet, and J. Cosnes Environmental risk factors in Crohn's disease and ulcerative colitis: an update Gastroenterol Clin Biol 33 2009 S145 S157
6. C.N. Bernstein New insights into IBD epidemiology: are there any lessons for treatment? Dig Dis 28 2010 406 410
7. M.D. Kappelman, S.L. Rifas-Shiman, and K. Kleinman The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States Clin Gastroenterol Hepatol 5 2007 1424 1429
8. L.M. Ward, F. Rauch, and M.A. Matzinger Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease Osteoporos Int 21 2010 331 337
9. K. Karolewska-Bochenek, I. Lazowska-Przeorek, and P. Albrecht Epidemiology of inflammatory bowel disease among children in Poland. A prospective, population-based, 2-year study, 2002-2004 Digestion 79 2009 121 129
10. F.M. Ruemmele, M.G. El Khoury, and C. Talbotec Characteristics of inflammatory bowel disease with onset during the first year of life J Pediatr Gastroenterol Nutr 43 2006 603 609
11. D.Y. Han, A.G. Fraser, P. Dryland, and L.R. Ferguson Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand Mutat Res 690 2010 116 122
12. T. Nagaishi, Z. Chen, and L. Chen CEACAM1 and the regulation of mucosal inflammation Mucosal Immunol 1 2008 S39 S42
13. B. Siegmund Targeted therapies in inflammatory bowel disease Dig Dis 27 2009 465 469
14. E. Scapa, M.G. Neuman, and J. Eshchar Inflammatory bowel disease and serum beta-N-acetyl-hexosaminidase Enzyme 43 1990 146 150
15. P. Jacobson-Brown, and M.G. Neuman Colorectal polyposis and immune-based therapies Can J Gastroenterol 18 2004 239 249
16. L.R. Ferguson, A.N. Shelling, B.L. Browning, C. Huebner, and I. Petermann Genes, diet and inflammatory bowel disease Mutat Res 622 2007 70 83
17. M. O'Sullivan, and C. O'Morain Nutrition in inflammatory bowel disease Best Pract Res Clin Gastroenterol 20 2006 561 573
18. X. Hébuterne, J. Filippi, R. Al-Jaouni, and S. Schneider Nutritional consequences and nutrition therapy in Crohn's disease Gastroenterol Clin Biol 33 2009 S235 S244
19. B. Avinash, A.K. Dutta, and A. Chacko Pediatric inflammatory bowel disease in South India Indian Pediatr 46 2009 639 640
20. L. Valentini, and J.D. Schulzke Mundane, yet challenging: the assessment of malnutrition in inflammatory bowel disease Eur J Intern Med 22 2011 13 15
21. G.C. Nguyen, M. Munsell, and M.L. Harris Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients Inflamm Bowel Dis 14 2008 1105 1111
22. K. Vagianos, S. Bector, J. McConnell, and C.N. Bernstein Nutrition assessment of patients with inflammatory bowel disease JPEN J Parenter Enteral Nutr 31 2007 311 319
23. D.D. Mijač, G.L. Janković, J. Jorga, and M.N. Krstić Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment Eur J Intern Med 21 2010 315 319
24. R.S. Sappati Biyyani, B.S. Putka, and K.D. Mullen Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease J Clin Lipidol 4 2010 478 482
25. Y. Ueda, Y. Kawakami, and D. Kunii Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease Nutr Res 28 2008 239 244
26. IBD in EPIC Study Investigators Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study Gut 58 2009 1606 1611
27. K. Gerasimidis, P. McGrogan, K. Hassan, and C.A. Edwards Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease Aliment Pharmacol Ther 27 2008 155 165
28. L.A. Brunborg, T.M. Madland, and R.A. Lind Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil Clin Nutr 27 2008 614 622
29. T. Bjorkkjær, J.G. Brun, and M. Valen Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease Lipids Health Dis 5 2006 6
30. C. Hartman, D. Berkowitz, and B. Weiss Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohn's disease Isr Med Assoc J 10 2008 503 507
31. G.C. Nguyen, T.A. Laveist, and S.R. Brant The utilization of parenteral nutrition during the in-patient management of inflammatory bowel disease in the United States: a national survey Aliment Pharmacol Ther 26 2007 1499 1507
32. K. Fyderek, M. Strus, and K. Kowalska-Duplaga Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease World J Gastroenterol 15 2009 5287 5294
33. J.E. Teitelbaum, and M. Triantafyllopoulou Inflammatory bowel disease and Streptococcus bovis Dig Dis Sci 51 2006 1439 1442
34. H. Sokol, N. Vasquez, and N. Hoyeau-Idrissi Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis World J Gastroenterol 16 2010 583 587
35. G. Hörmannsperger, and D. Haller Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease Int J Med Microbiol 300 2010 63 73
36. M. Weng, W.A. Walker, and I.R. Sanderson Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia Pediatr Res 62 2007 542 546
37. D. Philippe, E. Heupel, S. Blum-Sperisen, and C.U. Riedel Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis Int J Food Microbiol 149 2010 45 49
38. H.Q. Huynh, J. deBruyn, and L. Guan Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study Inflamm Bowel Dis 15 2009 760 768
39. L.R. Ferguson, A.N. Shelling, D. Lauren, J.A. Heyes, and W.C. McNabb Nutrigenomics and gut health Mutat Res 622 2007 1 6
40. D. Haller Nutrigenomics and IBD: the intestinal microbiota at the cross-road between inflammation and metabolism J Clin Gastroenterol 44 2010 S6 S9
41. G. Lee, and A.L. Buchman DNA-driven nutritional therapy of inflammatory bowel disease Nutrition 25 2009 885 891
42. B. De Vroey, C. De Cassan, C. Gower-Rousseau, and J.F. Colombel Editorial: Antibiotics earlier, IBD later? Am J Gastroenterol 105 2010 2693 2696
43. S.Y. Shaw, J.F. Blanchard, and C.N. Bernstein Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease Am J Gastroenterol 105 2010 2687 2692
44. A. Hviid, H. Svanström, and M. Frisch Antibiotic use and inflammatory bowel diseases in childhood Gut 60 2011 49 54
45. D.J. Margolis, M. Fanelli, O. Hoffstad, and J.D. Lewis Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease Am J Gastroenterol 105 2010 2610 2616
46. S. Singh, L.A. Graff, and C.N. Bernstein Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol 104 2009 1298 1313
47. U. Navaneethan, P.G. Venkatesh, and B. Shen Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship World J Gastroenterol 16 2010 4892 4904
48. D. Wultańska, A. Banaszkiewicz, and A. Radzikowski Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease Eur J Clin Microbiol Infect Dis 29 2010 1265 1270
49. S. Ben-Horin, M. Margalit, and P. Bossuyt Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection Clin Gastroenterol Hepatol 7 2009 981 987
50. E.M. Clayton, M.C. Rea, and F. Shanahan The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission Am J Gastroenterol 104 2009 1162 1169
51. A. Pillai, and R. Nelson Probiotics for treatment of Clostridium difficile-associated colitis in adults Cochrane Database Syst Rev 2008 CD004611
52. R.A. Juste, N. Elguezabal, and J.M. Garrido On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease PLoS One 3 2008 e2537
53. J.F. Blanchard, C.N. Bernstein, A. Wajda, and P. Rawsthorne Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis Am J Epidemiol 154 2001 328 335